Results 131 to 140 of about 2,131 (185)

Persistent cognitive dysfunction in patients with migraine: a case series. [PDF]

BMC Neurol
Kashihara K, Takeda Y, Irisawa M.
europepmc   +1 more source

Number Needed to Treat and Cost Per Responder Analysis of Anti-CGRP Monoclonal Antibodies for Migraine Prevention in Adults for Whom Prior Preventive Treatments have Failed. [PDF]

Adv Ther
Mitsikostas DD, Awad SF, Kongerslev R, Boserup LP, Lee XY, Phul R, Sacco S.   +6 more
europepmc   +1 more source

CGRP-Targeting Therapies in Vestibular Migraine: A Synthesis of Observational Evidence with Direction-of-Effect Analysis. [PDF]

Med Sci (Basel)
Ciubotaru A, Mastaleru A, Schreiner TG, Grosu C, Alexa D, Oancea A, Vamanu A, Roceanu AM, Cucu AI, Pana BI, Cozma RS, Olariu R, Dan Iulian C, Ignat EB.   +13 more
europepmc   +1 more source

Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder: The UNITE Randomized Clinical Trial. [PDF]

JAMA Neurol
Lipton RB, Ramirez Campos V, Roth-Ben Arie Z, Galic M, Mitsikostas D, Tassorelli C, Denysenko L, Cohen JM.   +7 more
europepmc   +1 more source

Patient-Reported Adherence, Knowledge and Perceived Outcomes After Specialist Nursing Education in a Multidisciplinary Headache Unit: A Cross-Sectional Observational Study. [PDF]

Nurs Rep
Ruiz-Castrillo MJ, Portocarrero-Sánchez L, Zaballa-Pérez L, Sánchez-Huertas A, Díaz-de-Terán J.   +4 more
europepmc   +1 more source

A real-world study of the efficacy and tolerability of fremanezumab in migraine patients with a median follow-up of 14 months. [PDF]

Neurol Res Pract
Suzuki S, Suzuki K, Haruyama Y, Fujita H, Shiina T, Kobayashi S, Shioda M, Hida R, Hirata K.   +8 more
europepmc   +1 more source

Assessing the Occurrence of Hypertension in Patients Receiving Calcitonin Gene-Related Peptide Monoclonal Antibodies for Episodic and Chronic Migraine: A Systematic Review. [PDF]

Cureus
Kakde SP, Islam K, Ali MF, Anwar MS, Nadeem L, Rana AR, Rana AW, Hayat SK, Ali SM, Kolanu ND.   +9 more
europepmc   +1 more source

Prescription of Monoclonal Antibodies Against Calcitonin Gene-Related Peptide for the Prophylaxis of Migraine in Austria: A Retrospective, Longitudinal Analysis of Nationwide Insurance Data. [PDF]

Eur J Neurol
Zebenholzer K, Gleiss A, Reichardt B, Gall W, Wöber C.   +4 more
europepmc   +1 more source

Real-World Characteristics and Treatment Patterns of Calcitonin Gene-Related Peptide Monoclonal Antibody Users: a Japanese Claims Database-Based Study. [PDF]

Pain Ther
Takizawa T, Takemura R, Ueda K, Miki Y, Hashimoto C.   +4 more
europepmc   +1 more source

Patient Adherence and Long-Term Tolerability of Anti-calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibodies in Migraine Prevention: A Systematic Review. [PDF]

Cureus
Ray R, Virk GS, Regmi N, Shafiq MM, Siddique R, Elfatih Elamin A, Jihad Y, Ali A, Devi H, Essani B.   +9 more
europepmc   +1 more source